Literature DB >> 14051903

DIHYDRO-1,3-OXAZINES AS ANTITUMOR AGENTS.

M E KUEHNE, E A KONOPKA.   

Abstract

Entities:  

Keywords:  ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CARCINOMA, EHRLICH TUMOR; CHEMISTRY; EXPERIMENTAL LAB STUDY; LEUKEMIA L1210; MICE; OXAZINES; PHARMACOLOGY; SARCOMA 180, CROCKER

Mesh：

Substances：

Year:  1962        PMID： 14051903     DOI： 10.1021/jm01237a005

Source DB:  PubMed          Journal:  J Med Pharm Chem        ISSN： 0095-9065


× No keyword cloud information.
  5 in total

1.  Design, synthesis and biological evaluation of 2H-benzo[b][1,4] oxazine derivatives as hypoxia targeted compounds for cancer therapeutics.

Authors:  Bhaskar C Das; Ankanahlli V Madhukumar; Jaime Anguiano; Sridhar Mani
Journal:  Bioorg Med Chem Lett       Date:  2009-06-02       Impact factor: 2.823

Review 2.  PROGRESS IN CHEMOTHERAPY OF CANCER.

Authors:  W DAVIS; L F LARIONOV
Journal:  Bull World Health Organ       Date:  1964       Impact factor: 9.408

3.  Redox-neutral α-oxygenation of amines: reaction development and elucidation of the mechanism.

Authors:  Matthew T Richers; Martin Breugst; Alena Yu Platonova; Anja Ullrich; Arne Dieckmann; K N Houk; Daniel Seidel
Journal:  J Am Chem Soc       Date:  2014-04-14       Impact factor: 15.419

4.  QSAR Studying of Oxidation Behavior of Benzoxazines as an Important Pharmaceutical Property.

Authors:  Elham Baher; Naser Darzi
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

5.  Synthesis of meso-substituted dihydro-1,3-oxazinoporphyrins.

Authors:  Satyasheel Sharma; Mahendra Nath
Journal:  Beilstein J Org Chem       Date:  2013-03-07       Impact factor: 2.883
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.